Skip to main content
. 2022 Aug 30;57:75–79. doi: 10.1016/j.hrtlng.2022.08.023

Table 3.

Comparison of TTE and TCT findings.

*Severe involvement
(n = 48) *Non-severe involvement
(n = 21) *No involvement
(n = 22)
sPAP, mmHg 31.89 ± 6.98*# 21.10 ± 4.68 17.90 ± 2.09
mPAP, mmHg 21.23 ± 4.33*# 14.15 ± 3.27 12.50 ± 1.50
RV basal diameter, mm 31.52 ± 2.93*# 27.84 ± 2,85 25.59 ± 2.53
RV mid diameter, mm 31.63 ± 2.76*# 28.52 ± 2.91 25.86 ± 3.22
RV longitudinal dimension, mm 75.91 ± 5.70*# 66.05 ± 4.61 65.72 ± 4.75
TAPSE, mm 19.31 ± 2.62 20.47 ± 2.26 21.05 ± 1.27
LVEF, % 59.77 ± 3.22 60.73 ± 3.73 61.31 ± 2.66
Left atrium diameter, mm 37.76 ± 3.19 36.84 ± 3.00 34.81 ± 3.86
LVESD, mm 30.95 ± 3.32 31.05 ± 5.32 28.81 ± 2.95
LVEDD, mm 49.17 ± 3.29 47.42 ± 4.54 46.77 ± 3.49

Data are presented as mean ± SD. sPAP: systolic pulmonary artery pressure; mPAP: mean pulmonary artery pressure; RV: right ventricle; LV: left ventricle; LVEF: left ventricular ejection fraction; LVESD: LV end-systolic diameter; LVEDD: LV end-diastolic diameter; TAPSE: tricuspid annular plane systolic excursion.*Based on TCT severity score.9

*P < 0.001 vs. non-severe involvement.

#P < 0.001 vs. no-involvement.

†P < 0.05 vs. no-involvement.